pCMV-PEmax-P2A-GFP Citations (3)

Originally described in: Enhanced prime editing systems by manipulating cellular determinants of editing outcomes.
Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen PF, Chen C, Nelson JW, Newby GA, Sahin M, Osborn MJ, Weissman JS, Adamson B, Liu DR Cell. 2021 Oct 28;184(22):5635-5652.e29. doi: 10.1016/j.cell.2021.09.018. PubMed Journal

---

Articles Citing pCMV-PEmax-P2A-GFP

Articles
Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene. Hasan MN, Hyodo T, Biswas M, Rahman ML, Mihara Y, Karnan S, Ota A, Tsuzuki S, Hosokawa Y, Konishi H. PLoS One. 2023 Nov 9;18(11):e0294146. doi: 10.1371/journal.pone.0294146. eCollection 2023. PubMed
Prime-Editing of human ACTB in induced pluripotent stem cells to model human ACTB Loss-of-Function diseases and compensatory mechanisms. Binder S, Ramachandran H, Hildebrandt B, Dobner J, Rossi A. Stem Cell Res. 2024 Mar;75:103304. doi: 10.1016/j.scr.2024.103304. Epub 2024 Jan 3. PubMed
Precise editing of pathogenic nucleotide repeat expansions in iPSCs using paired prime editor. Hwang HY, Gim D, Yi H, Jung H, Lee J, Kim D. Nucleic Acids Res. 2024 Jun 10;52(10):5792-5803. doi: 10.1093/nar/gkae310. PubMed

If you have published an article using this material, please email us at to have your article added to this page.